Massachusetts Financial Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.1M | Buy |
|
|||||
|
2025
Q1 | $96.9M | Sell |
|
|||||
|
2024
Q4 | $112M | Buy |
|
|||||
|
2024
Q3 | $138M | Buy |
|
|||||
|
2024
Q2 | $127M | Sell |
|
|||||
|
2024
Q1 | $124M | Sell |
|
|||||
|
2023
Q4 | $150M | Buy |
|
|||||
|
2023
Q3 | $115M | Buy |
|
|||||
|
2023
Q2 | $41.7M | Sell |
|
|||||
|
2023
Q1 | $40.9M | Sell |
|
|||||
|
2022
Q4 | $40.9M | Sell |
|
|||||
|
2022
Q3 | $60.9M | Buy |
|
|||||
|
2022
Q2 | $35.1M | Sell |
|
|||||
|
2022
Q1 | $43.3M | Sell |
|
|||||
|
2021
Q4 | $50.3M | Buy |
|
|||||
|
2021
Q3 | $57.7M | Buy |
|
|||||
|
2021
Q2 | $34.3M | Buy |
|
|||||
|
2021
Q1 | $9.92M | Sell |
|
|||||
|
2020
Q4 | $17.1M | Sell |
|
|||||
|
2020
Q3 | $34.6M | Sell |
|
|||||
|
2020
Q2 | $49.8M | Sell |
|
|||||
|
2020
Q1 | $70.3M | Sell |
|
|||||
|
2019
Q4 | $89.2M | Sell |
|
|||||
|
2019
Q3 | $107M | Sell |
|
|||||
|
2019
Q2 | $210M | Sell |
|
|||||
|
2019
Q1 | $433M | Sell |
|
|||||
|
2018
Q4 | $575M | Buy |
|
|||||
|
2018
Q3 | $658M | Sell |
|
|||||
|
2018
Q2 | $608M | Buy |
|
|||||
|
2018
Q1 | $569M | Buy |
|
|||||
|
2017
Q4 | $583M | Buy |
|
|||||
|
2017
Q3 | $561M | Sell |
|
|||||
|
2017
Q2 | $499M | Buy |
|
|||||
|
2017
Q1 | $370M | Buy |
|
|||||
|
2016
Q4 | $16.1M | Buy |
|
|||||
|
2016
Q3 | $17.6M | Buy |
|
|||||
|
2016
Q2 | $13.3M | Sell |
|
|||||
|
2016
Q1 | $32.4M | Sell |
|
|||||
|
2015
Q4 | $114M | Sell |
|
|||||
|
2015
Q3 | $234M | Sell |
|
|||||
|
2015
Q2 | $629M | Buy |
|
|||||
|
2015
Q1 | $631M | Buy |
|
|||||
|
2014
Q4 | $491M | Sell |
|
|||||
|
2014
Q3 | $549M | Buy |
|
|||||
|
2014
Q2 | $497M | Buy |
|
|||||
|
2014
Q1 | $405M | Buy |
|
|||||
|
2013
Q4 | $350M | Buy |
|
|||||
|
2013
Q3 | $284M | Buy |
|
|||||
|
2013
Q2 | $207M | Buy |
|